Abstract In this study, we evaluate the potential involvement of collagenase-3 (MMP13), a matrix metalloproteinase (MMP) family member, in the exudative form of age-related macular degeneration characterized by a neovascularisation into the choroid. RT-PCR analysis revealed that human neovascular membranes issued from patients with AMD expressed high levels of Mmp13. The contribution of MMP13 in choroidal neovascularization (CNV) formation was explored by using a murine model of laser-induced CNV and applying it to wild-type mice (WT) and Mmp13-deficient mice (Mmp13 -/-mice). Angiogenic and inflammatory reactions were explored by immunohistochemistry. The implication of bone marrow (BM)-derived cells was determined by BM engraftment into irradiated mice and by injecting mesenchymal stem cells (MSC) isolated from WT BM. The deficiency of Mmp13 impaired CNV formation which was fully restored by WT BM engraftment and partially rescued by several injections of WT MSC. The present study sheds light on a novel function of MMP13 during BMdependent choroidal vascularization and provides evidence for a role for MSC in the pathogenesis of CNV. 
Introduction
Age-related macular degeneration (AMD) is one of the most common irreversible causes of blindness among people over 50 years [1] . Ninety percent of all vision loss due to AMD occurs in the exudative form which is characterized by choroidal neovascularization (CNV). The newly formed blood vessels arising from choriocapillaries are directed to the subretinal macular region with subsequent bleeding and/or fluid leakage into the subretinal space, local retinal detachment and retinal photoreceptor damage [2] . The pathophysiology of AMD is complex and age-related changes that induce pathologic neovascularization are incompletely understood. In combination with the rapidly growing knowledge on basic mechanisms in angiogenesis, new evidence in pathogenesis of macular disease has led to novel developments in therapeutic strategies. Indeed, angiogenic factors such as VEGF play an important role in choroidal neovascular formation [3] [4] [5] and anti-VEGF molecules represent a substantial tool against AMD [4] . In the process of CNV, the vascular overgrowth is coupled with a localized proteolysis, extracellular remodelling and cell migration involving different proteolytic systems among which the matrix metalloproteinases (MMPs) are key players [4, 6, 7] .
An involvement of MMPs in the progression of retinal and choroidal neoangiogenesis is supported by both experimental and clinical data. A mutation of Timp-3 gene (tissue inhibitor of metalloproteinase-3) is the cause of a rare familial form of macular dystrophy associated with subretinal neovascularisation [8] [9] [10] . We previously reported the contribution of different MMPs, such as MMP2 or MMP9, in a mouse model of choroidal neovascularisation [11] . Here, we focused our interest on MMP13, an important collagenase displaying distinct properties compared with the other collagenases: MMP1 (interstitial collagenase), MMP8 (neutrophil collagenase) and MMP14 (MT1-MMP) [12] . MMP13 has the capacity to cleave native fibrillar collagen types I, II, III, and V as well as several other extracellular matrix (ECM) components, including type IV, X, and XIV collagens, large tenascin C, fibronectin, aggrecan, versican and fibrillin [13] [14] [15] [16] [17] . A role for MMP13 in cartilage matrix degradation has been proposed based on its expression during endochondral ossification and its particular potential to degrade type II collagen [18, 19] . An involvement of MMP13 in angiogenesis has been documented in the chorioallantoic membrane (CAM) of the chick embryos [20] , in bone fracture healing [19] and in the maintenance of the angiogenic response induced in developing skin carcinomas [21] . Nevertheless, a possible involvement of MMP13 in the neovascularization associated with ocular diseases has not been examined.
In the current study, we provide evidence for MMP13 expression in late stages of human exudative AMD and investigate the potential role of MMP13 in choroidal angiogenesis in a murine model of laser-induced ocular neovascularisation. We demonstrate the contribution of MMP13 in experimental CNV and a MSC-mediated modulation of this angiogenic process.
Materials and methods

Mice
Homozygous Mmp13-deficient mice (Mmp13 -/-) and the corresponding wild-type mice (WT) were generated in C57BL/6 background as previously described [22] . Mice expressing a single copy of a transgene that encodes the enhanced green fluorescent protein (eGFP) under the control of b-actin promoter C57BL/6-Tg(ACTbEGFP)10sb were obtained from the Jackson Laboratories (Bar Harbor, ME, USA). Experimental procedures were performed in accordance to the guidelines of the University of Liège regarding the care and use of laboratory animals and are in line with the ''Ethical principles and guidelines for scientific experiments on animals'' of the Swiss Academy of Medical Sciences.
BM transplantation BM cells were isolated from the tibia and femur of donor mice (8-10 weeks of age) by slowly flushing DMEM culture medium (Gibco BRL, Paisley, UK) into the diaphyseal channel. Recipient mice (8-10 weeks old) sublethally irradiated with a single dose of 9 Gy were injected intravenously (i.v.) with BM cells (10 7 per animal). At 5 weeks after BM transplantation, impact laser burns were performed. The success of BM transplantation was assessed as previously described [23] .
CNV model CNV was induced in both eyes of mice by photocoagulation with laser burns as previously described [24] . After 14 days (or earlier time points in kinetic analysis), animals were killed and both eyes were enucleated (n = 4-8 animals per experimental condition with four lesions per eye). For immunohistochemical analysis, eyes were embedded in Tissue Tek for cryostat sectioning. Neovascularization was estimated by computer-assisted measurement on at least five sections per lesion of the b/c ratio (b, thickness from the bottom of the pigmented choroidal layer to the top of the neovascular membrane; c, thickness of the intact pigmented choroid adjacent to the lesion) as previously described [5, 11, 25] .
For confocal visualization of the vasculature, mice were injected i.v. with 200 ll of fluorescein isothiocyanate (FITC)-conjugated dextran (2 9 10 3 kDa average molecular weight; Sigma) (50 mg/ml). After 1 h of fixation in paraformaldehyde 1% (pH 7.4), retinas were removed and choroids were flat-mounted using Vectashield mounting medium (Vector Laboratories, Burlingame, CA, USA). Spatial distribution of fluorescence was examined using a Leica TCS SP2 inverted confocal laser microscope (Leica Microsystems, Wetzlar, Germany) equipped with one argon and two helium-neon lasers and an acousto-optical tuneable filter for excitation intensity. FITC was visualized by using an excitation wavelength of 488 nm, and the emission light was dispersed and recorded from 500 to 535 nm. For each lesion, serial optical sections were recorded with a z-step of 1.67 lm. After successive scanning for each interval, 3D fluorescent images were constructed by using Leica confocal software. The area and the volume of CNV on choroidal flatmount were determined using the image analysis toolbox of MATLAB 7.9 software.
Human neovascular membranes Submacular CNV specimens were obtained during surgery for 360°macular translocation performed on patients (n = 3) with exudative AMD, either not amenable to conventional laser/photodynamic therapy (presence of occult new vessels or submacular bleeding), or in one patient, due to a severe recurrence a few months after a successful medical treatment [26] . The neovascular membranes were snap frozen in liquid nitrogen and stored at -80°C. Intact posterior segments from healthy donors (Cornea Bank, Liège, Belgium) collected maximum 8 h after death were used as controls (n = 4). GAPDH was used as a control to check for RNA degradation. The methods conformed to the Declaration of Helsinki for research involving human subjects.
RNA extraction in experimental CNV
To evaluate the kinetics of MMP expression, CNV was induced in mice by multiple argon laser burns and animals were killed at days 3, 5, 7 and 14. The posterior segments (RPE-choroid complex without neural retina) were cut out and immediately frozen in liquid nitrogen. Total RNA was extracted (RNeasy extraction kit; Quiagen, Paris, France) according to the protocol of the manufacturer.
In some assays, choroidal neovascular membranes and adjacent neural retina intact regions were separately extracted from frozen sections by laser capture microdissection [laser pressure catapulting (LPC) technique] as previously described [27] . Total RNA isolation was performed (TRIzol Reagent; Life Technologies, Carlsbad, CA, USA) according to the manufacturer's protocol.
RT-PCR analysis
RT-PCR was done on 10 ng of total RNA extracted from tissue using a GeneAmp Thermostable rTth Reverse Transcriptase RNA PCR kit (Applied Biosystems, Foster City, CA, USA) following manufacturer's instructions. Specific pairs of primers (Eurogentec, Seraing, Belgium) for mouse Mmp13 were designed as follows: forward (exon 6), ATGATCTTTAAAGACAGATTCTTCTGC-3 0 ; reverse (exon 7), 5 0 -TGGGATAACCTTCCAGAATGTCA TAA-3 0 . Amplification of 35 cycles was run for 15 s at 94°C, 20 s at 68°C, and 30 s at 72°C. Quantification of Mmp13 expression was normalized to 28S signal. Note that the mutation in Mmp13 -/-mice is in exon 5 that encodes the critical catalytic domain of the enzyme. This exon is spliced out in the Mmp13 -/-mice [22] .
Immunohistochemistry
Cryostat sections (6 lm thick) were fixed in acetone at -20°C and in methanol 80% at 4°C before incubation with primary antibodies (Abs ? , CD34 -, CD45 -, CD11b -). Osteogenic, adipogenic and chondrogenic differentiation assays were performed on MSC as previously described [29] .
Statistical analyses
Data were analyzed with GraphPad Prism 4.0 (San Diego, CA, USA). The unpaired Student's t test was used to determine the significance (p \ 0.05) of differences between experimental groups (*p \ 0.05, **p \ 0.01, ***p \ 0.001). (Fig. 1a) . In sharp contrast, a faint basal expression of Mmp13 mRNA was detected in some control specimens (in or out of the macula) collected from healthy donors. The expression of 28S rRNA and Gapdh mRNA was used as a control to assess the good preservation of mRNA in AMD patients and healthy donors.
Results
Mmp13
In mouse, photocoagulation with an argon laser induced a trauma leading to the formation of choroidal neovascular lesions under the retina. RT-PCR analysis revealed that levels of Mmp13 mRNA were low in the early stage of lesion formation and then progressively increased from day 5 to day 7 (p \ 0.05). From day 7 to day 14, coinciding with the period of stabilization, Mmp13 mRNA levels did not progress any further (p = 0.3627) (n = 8) (Fig. 1a) . Mmp13 mRNAs were specifically detected on microdissected neovascular choroidal membranes from WT mice, but not from Mmp13 -/-mice. Neighboring intact chorioretinal areas were negative for Mmp13 mRNA, confirming that Mmp13 expression was locally induced during the photocoagulation (Fig. 1b) . Immunohistochemical analysis confirmed the presence of MMP13 protein in the neovascular lesions in WT mice (Fig. 3a, b) .
Mmp13-deficiency impairs choroidal neovascularization
Retinal damage and CNV were estimated by measuring different parameters: the area of CNV on choroidal flatmounts observed by confocal microscopy (Fig. 2a) and the ratio between the maximal height of the lesion (b) and the thickness of the normal choroid (c) observed in the neighburing intact zones (b/c ratio) determined on tissue sections (Fig. 2b) [5] . A reduced neovascularization was observed in Mmp13 -/-mice as compared to WT mice. The analysis by confocal microscopy of flatmounted choroids revealed a two-fold reduction of vessel area (Fig. 2a) . Similar results were obtained by measuring the volume of vascularisation through a 3D analysis (0.11 9 10 6 lm 3 ± 0.03 9 10 6 SEM in WT mice vs 0.05 9 10 6 lm 3 ± 0.01 9 10 6 SEM in Mmp13 -/-mice; p = 0.047). The severity of neovascularisation was also estimated histologically on serial sections by measuring the maximal height of lesion (b) above the thickness of the normal choroid observed in neighboring intact zones (c). In Mmp13 -/-mice, the b/c ratio was significantly reduced in comparison to WT mice (p \ 0.0001) (Fig. 2b) . Newly formed blood vessels were characterized by immunostaining of endothelial cells (PECAM positive cells) and perivascular cells (aSMA positive cells) or pericytes (NG2 positive cells) (Fig. 3c-f) . While newly formed vessels were ''naked'' in Mmp13 -/-mice, they were covered by NG2
? cells and aSMA ? cells in WT mice. Indeed, the percentage of NG2/SMA co-localization was ten-fold higher in WT mice as compared to Mmp13 -/-mice (9.18 ± 3.45 in WT vs 0.97 ± 0.39 in KO mice). These results reveal that Mmp13 deficiency not only affected vessel recruitment, but also impaired their maturation through pericyte coverage.
The inflammatory reaction was next explored by immunostaining of CD11b (Fig. 3g, h ) and neutrophils (Fig. 3i, j) . In accordance with our previous data [23] , inflammatory cells were not detected before injury induction (at day 0) and appeared at day 3 post-injury. No significant difference in the number of inflammatory CD11b
? cells was observed in Mmp13-deficient mice (0.077 ± 0. mice. Five weeks after BM transplantation (i.e., after allowing for BM reconstitution), laser burns were performed to induce CNV. Genotyping of spleen was performed for all animals to assess BM transplantation success. New blood vessel formation was quantified by both flatmount and histological analysis. When irradiated mice were reconstituted with BM from WT mice, a slight decrease but not significant (p [ 0.05) in vessel formation was observed in grafted mice as compared to ungrafted mice (Fig. 4) . Interestingly, a complete restoration of the CNV was observed in Mmp13 -/-mice engrafted with WT BM. In this experimental group, lesion formation was similar to that observed in WT mice engrafted with WT BM and significantly higher than that of Mmp13 -/-mice engrafted with Mmp13 -/-BM (p = 0.0097). Moreover, the engraftment of Mmp13-deficient BM into WT mice significantly decreased lesion formation in comparison to WT control mice (p = 0.0009) (Fig. 4) . Similar results were obtained by evaluating lesion formation through confocal analysis of flatmount choroids (Fig. 4a) and through histological analysis of eye sections (Fig. 4b) .
BM-derived MSC are implicated in Mmp13-mediated choroidal angiogenesis
Effects of BM-produced MMP13 could not only be attributed to hematopoietic cells but also to MSC. It has been described that MMP13 is mainly expressed by mesenchymal cells [21] . To provide new insights into the type of BM-derived cells involved in lesion formation, we isolated MSC from WT BM. The expression of Mmp13 by MSC-cultured cells was assessed by RT-PCR analysis. Mmp13 mRNA is more expressed by isolated MSC than by whole BM (Fig. 5b) . MSC were then i.v. injected at days 1, 3, 7 and 10 post-laser injury. Interestingly, MSC injection into WT mice did not affect lesion formation (Fig. 5a) . In contrast, a partial restoration of lesion formation was observed in Mmp13-deficient mice injected with WT MSC. These results demonstrate a contribution of MSC in choroidal neovascular lesion formation mediated by MMP13.
Discussion
Through a genetic approach, the present study provides evidences for a contribution of MMP13 during BMdependent CNV in a mouse model of laser burn-induced CNV. This concept is supported by [1] the increased expression of Mmp13 during the course of CNV induction, [2] the impaired CNV in Mmp13 -/-mice and [3] the restoration of CNV in Mmp13 -/-mice by the engraftment of BM or the injection of MSC derived from WT mice. These experimental findings are consistent with the expression of MMP13 detected in late stages of human exudative AMD.
The contribution of MMP13 in angiogenesis has been previously documented in a physiological model of angiogenesis, the CAM assay [20] . In this system, purified chicken MMP13 elicited an angiogenic response in the CAM onplant comparable to that induced by angiogenic growth factors. In line with our finding of angiogenesis dysfunction in Mmp13-deficient mice is the observation of defective vascular penetration into the fracture callus observed in a murine model of bone fracture healing [19] , impaired tumoral angiogenesis in murine models of skin carcinomas [21] , and delayed vascularization of primary ossification centres in Mmp13 -/-mice during embryonic development [22] . Our work extends the role of MMP13 to pathological angiogenesis and specifically to ocular diseases such as AMD.
The action of MMP13 in CNV can involve different mechanisms. As a principal interstitial collagenase, MMP13 could contribute to tissue remodeling paving the way for endothelial cell migration. We found, however, that collagen deposition assessed by saffron staining did not reveal differences between genotypes (data not shown). MMP13 could also participate in a proteolysis cascade including MT1-MMP, MMP2 and MMP9 [30] . Indeed, the latter MMPs could have the most critical function in ECM remodeling occurring during angiogenesis associated with AMD. In this context, we previously reported the key contribution of MMP2 and MMP9 in CNV [11] . A pro- . PECAM (red) and NG2 (green) (c,e) or aSMA (green) (e,f) double immunostaining (day 14). g,h Labeling of inflammatory cells using CD11b antibody (day 5). i,j Staining of neutrophils (day 5). White bars represent 100 lm; yellow dotted line delineate the lesion; R retina, Ch choroid, inserts represent a twofold higher magnification of initial pictures angiogenic effect of MMP13 may also require release from cryptic sites of angiogenic factors such as bFGF [31] or VEGF [21] . A combination of different mechanisms of action cannot be excluded. The present demonstration that MMP13 plays a role in CNV provides an incentive to further study the mechanisms underlying the pro-angiogenic functions of MMP13.
An unexpected finding of our work is the contribution of BM-derived cells to the pro-angiogenic action of MMP13. The formation of choroidal neovascular lesion may involve different mechanisms such as angiogenesis (the endothelial cell spouting from pre-existing vessels) and vasculogenesis (the recruitment of BM-derived cells) [23, 32, 33] . We and others previously demonstrated the recruitment of BMderived cells in CNV [23, [33] [34] [35] [36] . These observations are further supported by previous experiments in which GFP ? BM cells were engrafted into WT mice [23, [33] [34] [35] [36] . Of interest is the demonstration here that WT BM-derived cells are sufficient to restore the vascularization impaired by Mmp13 deficiency. This report provides the first experimental evidence for a key role played by BMderived MMP13 in pathological ocular vascularization. This is in line with the levels of MMP13 expression reported in BM-derived cells that contributed to the pathology in a model of liver fibrosis [37] . It is worth noting that whole body irradiation followed by BM reconstitution can potentially affect neovascularization. Indeed, radiation is well known to cause damage to endothelial cells and to inhibit neovascularization by suppressing the recruitment of BM-derived endothelial cells [38] . Accordingly, a slight radiation-induced defect in neovascularization was observed in the present model. The present study demonstrates that Mmp13 -/-mice engrafted with WT BM displayed similar lesion formation to WT mice engrafted with WT BM revealing a restoration of the angiogenic response through BM transplantation.
The effect of BM-derived cells could be attributed to MSC, vascular progenitor cells and/or inflammatory cells which could migrate into reconstituted tissues or secrete soluble factors that mediate inflammation and angiogenesis. We previously demonstrated that several BM-derived cells could contribute to CNV development, such as inflammatory CD11b positive cells and/or mesenchymal cells positive for aSMA (myofibroblasts or vascular smooth muscle cells) [23] . In the current study, we demonstrate the key role in lesion formation played by Mmp13-expressing MSC. Indeed, four repetitive injections of MSC derived from WT mice partially rescued the impaired angiogenic phenotype in Mmp13 -/-mice. This partial restoration achieved with MSC injection as compared to the complete restoration of the phenotype achieved with BM engraftment could be explained either by a combined effect of different types of BM-derived cells, a transient effect of MSC or an insufficient supplementation of MSC through cell injections. Nevertheless, these data point to a novel role for MSC in CNV.
In conclusion, we have identified MMP13 as a key regulator of choroidal angiogenesis. Our findings extend the potential roles of MMP13 initially observed in cartilage/bone resorption [18] and tumor development [39, 40] to ocular diseases such as AMD. This pro-angiogenic effect of MMP13 is mainly mediated by BM-derived mesenchymal cells. These findings pave the way for therapeutic strategies based on the targeting of MMP13 with synthetic inhibitors or on the use of MSC as delivery vehicle for antiangiogenic agents as a ''Trojan horse'' approach [4] .
